Download - WHOCC

QM
MUSCULO-SKELETAL SYSTEM
Preparations used for treatment of disease in or symptoms of the musculo-skeletal
system can be classified in this group. Exceptions to this rule are listed under each
subgroup and cross-references to common agents and their classification group are
stated where appropriate. Many drugs classified in this group, such as the
antiinflammatory agents, commonly affect other organs as well. Included are both
topical products and products for systemic use. Corticosteroids for systemic use are,
with the exception of combinations with some antiinflammatory drugs, classified in
QH02 - Corticosteroids for systemic use.
QM01
QM01A
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-
STEROIDS
Antiinflammatory and antirheumatic preparations for systemic use should be
classified in this group.
Corticosteroids, see QH02 - Corticosteroids for systemic use. All products
containing salicylic acid and derivatives are classified in QN02BA - Salicylic acid
derivatives, with the exception of: salicylates in combination with corticosteroids,
which are classified in QM01B - Antiinflammatory/antirheumatic agents in
combination.
Combinations of antiinflammatory agents (e.g. corticosteroids) are classified in
QM01B - Antiinflammatory/antirheumatic agents in combination.
Antiinflammatory preparations in combination with other drugs (including codeine)
are classified at separate 5th level groups using the corresponding 50-series.
QM01AA
QM01AB
QM01AC
QM01AE
Butylpyrazolidines
Acetic acid derivatives and related substances
Oxicams
Propionic acid derivatives
Propionic acid derivatives are classified in this group, even if they are only intended
for use as pain relief.
QM01AG
QM01AH
QM01AX
Fenamates
Coxibs
Other antiinflammatory and antirheumatic agents, non-steroids
Antiinflammatory drugs which cannot be classified in the preceding groups should
be assigned to this group.
134